CTMX - CytomX Therapeutics, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.5 -0.12 (-3.43%)	---	---	---	-0.07 (-2.0%)	-0.04 (-1.16%)	0.0 (0.0%)	0.0 (0.0%)

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 3.38
RVol:: 0.4343

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.43 +0.04 (+1.18%)	Oct 15 11:58
1m	Price decrease 1m	3.4 -0.06 (-1.73%)	Oct 15 09:30
1m	Price increase 1m	3.51 +0.04 (+1.15%)	Oct 15 08:41
10m	Price increase 10m	3.5 +0.14 (+4.17%)	Oct 14 17:38